Navigation Links
Oncothyreon reports second quarter 2009 financial results
Date:8/12/2009

isease in the early dose cohorts in this ongoing dose escalation trial. - Improvement of Oncothyreon's financial position with the completion of two offerings of units consisting of shares of common stock and warrants, which generated combined net proceeds to Oncothyreon of approximately $24 million. - Strengthening of Oncothyreon's senior management team with the addition of Scott Peterson, Ph.D, as Vice President, Research and Development, and Diana Hausman, M.D., as Vice President, Clinical Development.

Conference Call and Webcast

Oncothyreon's management will discuss the Company's second quarter 2009 financial results and provide a business update during a conference call beginning at 1:30 p.m. PT/4:30 p.m. ET today, Wednesday, August 12, 2009. To listen to a webcast of the discussion, visit www.oncothyreon.com.

About Oncothyreon

Oncothyreon is a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer. Oncothyreon's goal is to develop and commercialize novel synthetic vaccines and targeted small molecules that have the potential to improve the lives and outcomes of cancer patients. For more information, visit www.oncothyreon.com.

Forward-Looking Statements

In order to provide Oncothyreon's investors with an understanding of our current results and future prospects, this release may contain statements that are forward-looking. Any statements contained in this press release that are not statements of historical fact may be deemed to be forward-looking statements. Words such as "believes," "anticipates," "plans," "expects," "will," "intends," "potential," "possib
'/>"/>

SOURCE Oncothyreon Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Biomira announces plan to change name to Oncothyreon
2. Oncothyreon highlights corporate and clinical objectives for 2008
3. Oncothyreon to present at BIO CEO & Investor Conference
4. Oncothyreon launches new corporate website
5. Oncothyreons PX-478 is effective in preclinical model of human lung cancer
6. Oncothyreon announces March 10th webcast of fourth quarter and full year financial results conference call
7. Oncothyreon reports full year and fourth quarter 2007 financial results
8. Oncothyreon to present at upcoming investment conferences
9. Oncothyreon announces issuance of patent for PX-867
10. Oncothyreon announces effectiveness of shelf registration statement
11. Oncothyreon announces data from multiple small molecule programs to be presented at American Association of Cancer Research Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology News(10 mins):Berkeley Lab researchers participate in Homeland Security study of subway airflow 2Potential new heart attack biomarker uncovered 2Successful stem cell therapy for treatment of eye disease 2Reportlinker Adds Medical Devices 26amp 3B Equipment in India 282009 29 5714 1Reportlinker Adds Medical Devices 26amp 3B Equipment in India 282009 29 5714 2Reportlinker Adds Medical Devices 26amp 3B Equipment in India 282009 29 5714 3Reportlinker Adds Medical Devices 26amp 3B Equipment in India 282009 29 5714 4Reportlinker Adds Medical Devices 26amp 3B Equipment in India 282009 29 5714 5Reportlinker Adds Medical Devices 26amp 3B Equipment in India 282009 29 5714 6Reportlinker Adds Medical Devices 26amp 3B Equipment in India 282009 29 5714 7Reportlinker Adds Medical Devices 26amp 3B Equipment in India 282009 29 5714 8Reportlinker Adds Medical Devices 26amp 3B Equipment in India 282009 29 5714 9Reportlinker Adds Medical Devices 26amp 3B Equipment in India 282009 29 5714 10Reportlinker Adds Medical Devices 26amp 3B Equipment in India 282009 29 5714 11Reportlinker Adds Medical Devices 26amp 3B Equipment in India 282009 29 5714 12Reportlinker Adds Medical Devices 26amp 3B Equipment in India 282009 29 5714 13Hutchinson Center to Build First U S Cancer Clinic and Training Facility in Africa Thanks in Part to a Grant From USAID 5711 1Hutchinson Center to Build First U S Cancer Clinic and Training Facility in Africa Thanks in Part to a Grant From USAID 5711 2Hutchinson Center to Build First U S Cancer Clinic and Training Facility in Africa Thanks in Part to a Grant From USAID 5711 3Hutchinson Center to Build First U S Cancer Clinic and Training Facility in Africa Thanks in Part to a Grant From USAID 5711 4Hutchinson Center to Build First U S Cancer Clinic and Training Facility in Africa Thanks in Part to a Grant From USAID 5711 5Hutchinson Center to Build First U S Cancer Clinic and Training Facility in Africa Thanks in Part to a Grant From USAID 5711 6MolSofts New Technology Brings Online Publications to Life in Fully Interactive 3D 5708 1MolSofts New Technology Brings Online Publications to Life in Fully Interactive 3D 5708 2